Changes in serum tryptophan catabolism as an indicator of disease activity in adult T-cell leukemia/lymphoma.
Hoshi
Masato
M
Ito
Hiroyasu
H
Fujigaki
Hidetsugu
H
Takemura
Masao
M
Takahashi
Takeshi
T
Tomita
Eiichi
E
Ohyama
Masami
M
Tanaka
Ryo
R
Ohtaki
Hirofumi
H
Saito
Kuniaki
K
Seishima
Mitsuru
M
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D016903:Drug Monitoring; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000378:metabolism; D007737:Kynurenine / Q000097:blood; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000097:blood* / Q000188:drug therapy / Q000201:enzymology; D053858:Metabolic Networks and Pathways; D009363:Neoplasm Proteins / Q000378:metabolism; D009360:Neoplastic Cells, Circulating; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy; D009607:Nitrosourea Compounds / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D015375:Receptors, Interleukin-2 / Q000097:blood; D014364:Tryptophan / Q000097:blood*; D014366:Tryptophan Oxygenase / Q000378:metabolism; D014750:Vincristine / Q000008:administration & dosage; D014751:Vindesine / Q000008:administration & dosage
D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D009363:Neoplasm Proteins; D009607:Nitrosourea Compounds; D015375:Receptors, Interleukin-2; D016179:Granulocyte Colony-Stimulating Factor; D007737:Kynurenine; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D014364:Tryptophan; D003520:Cyclophosphamide; D016190:Carboplatin; D014366:Tryptophan Oxygenase; D014751:Vindesine; C020766:ranimustine; D011241:Prednisone